Search
| Leader | 00000nz a2200037n 45 0 | ||
|---|---|---|---|
| 001 | WKP|Q90656407 (VIAF cluster) (Authority/Source Record) | ||
| 003 | WKP | ||
| 005 | 20241221010740.0 | ||
| 008 | 241221nneanz||abbn n and d | ||
| 035 | ‡a (WKP)Q90656407 | ||
| 024 | ‡a 0000-0003-4208-935X ‡2 orcid | ||
| 024 | ‡a 57204354437 ‡2 scopus | ||
| 035 | ‡a (OCoLC)Q90656407 | ||
| 100 | 0 | ‡a Cristina Calviño-Suárez ‡c researcher (ORCID 0000-0003-4208-935X) ‡9 en | |
| 400 | 0 | ‡a Cristina Calviño-Suárez ‡c wetenschapper ‡9 nl | |
| 670 | ‡a Author's Bismuth-containing quadruple therapy versus concomitant quadruple therapy as first-line treatment for Helicobacter Pylori infection in an area of high resistance to clarithromycin: A prospective, cross-sectional, comparative, open trial | ||
| 670 | ‡a Author's Exocrine Pancreatic Insufficiency Following Acute Pancreatitis: Systematic Review and Meta-Analysis | ||
| 670 | ‡a Author's Pouchitis: Treatment dilemmas at different stages of the disease | ||
| 670 | ‡a Author's Should We Investigate Respiratory Diseases in Inflammatory Bowel Disease Patients? | ||
| 909 | ‡a (scopus) 57204354437 ‡9 1 | ||
| 909 | ‡a (orcid) 000000034208935x ‡9 1 | ||
| 919 | ‡a shouldweinvestigaterespiratorydiseasesininflammatoryboweldiseasepatients ‡A Should We Investigate Respiratory Diseases in Inflammatory Bowel Disease Patients? ‡9 1 | ||
| 919 | ‡a pouchitistreatmentdilemmasatdifferentstagesofthedisease ‡A Pouchitis: Treatment dilemmas at different stages of the disease ‡9 1 | ||
| 919 | ‡a exocrinepancreaticinsufficiencyfollowingacutepancreatitissystematicreviewandmetaanalysis ‡A Exocrine Pancreatic Insufficiency Following Acute Pancreatitis: Systematic Review and Meta-Analysis ‡9 1 | ||
| 919 | ‡a bismuthcontainingquadrupletherapyversusconcomitantquadrupletherapyas1linetreatmentforhelicobacterpyloriinfectioninanareaofhighresistancetoclarithromycinaprospectivecrosssectionalcomparativeopentrial ‡A Bismuth-containing quadruple therapy versus concomitant quadruple therapy as first-line treatment for Helicobacter Pylori infection in an area of high resistance to clarithromycin: A prospective, cross-sectional, comparative, open trial ‡9 1 | ||
| 996 | ‡2 PLWABN|9814555776005606 | ||
| 996 | ‡2 BNC|981058510323006706 | ||
| 996 | ‡2 BNC|981058608212106706 | ||
| 996 | ‡2 RERO|A026506157 | ||
| 996 | ‡2 ISNI|0000000035887714 | ||
| 996 | ‡2 SUDOC|276134044 | ||
| 996 | ‡2 NTA|300941331 | ||
| 996 | ‡2 BNE|XX1007861 | ||
| 996 | ‡2 LC|n 97102305 | ||
| 996 | ‡2 SUDOC|055334377 | ||
| 996 | ‡2 NTA|230050387 | ||
| 996 | ‡2 BNE|XX819860 | ||
| 996 | ‡2 DNB|1267693940 | ||
| 996 | ‡2 SUDOC|108873722 | ||
| 996 | ‡2 SUDOC|238467082 | ||
| 996 | ‡2 ISNI|0000000355901036 | ||
| 996 | ‡2 DNB|171369882 | ||
| 996 | ‡2 ISNI|0000000389849176 | ||
| 996 | ‡2 BNE|XX6061477 | ||
| 996 | ‡2 LC|no2013075289 | ||
| 996 | ‡2 LC|n 93070562 | ||
| 996 | ‡2 LC|n 84186616 | ||
| 996 | ‡2 DNB|1056473649 | ||
| 996 | ‡2 BNF|13609032 | ||
| 996 | ‡2 J9U|987007426486805171 | ||
| 996 | ‡2 DNB|105651177X | ||
| 996 | ‡2 SUDOC|236373412 | ||
| 996 | ‡2 ISNI|0000000025184468 | ||
| 996 | ‡2 BNE|XX825113 | ||
| 996 | ‡2 DNB|1067830316 | ||
| 996 | ‡2 LC|no2012034594 | ||
| 996 | ‡2 NTA|128538805 | ||
| 996 | ‡2 ISNI|0000000031210247 | ||
| 996 | ‡2 BNC|981058613277206706 | ||
| 996 | ‡2 ISNI|0000000054319675 | ||
| 996 | ‡2 SUDOC|123304628 | ||
| 996 | ‡2 NUKAT|n 2007109302 | ||
| 997 | ‡a 0 0 lived 0 0 ‡9 1 |
